ENT (ear, nose, and throat) medical devices in India are regulated by CDSCO under the Medical Devices Rules, 2017 and classified into four risk classes — A, B, C, and D — across 78 notified device types. Class A and Class B ENT devices (such as adenotomes, audiometers, otoscopes, hearing aids, and ENT surgical microscopes) require the MD5 manufacturing license via Form MD3 from the State Licensing Authority, with fees of Rs. 5,000 plus Rs. 500 per device. Class C and Class D ENT devices (such as cochlear implants, ossicular prostheses, larynx prostheses, bone-conduction implant systems, and tympanic membrane contact hearing aids) require the MD9 manufacturing license via Form MD7 from the Central Licensing Authority, with fees of Rs. 50,000 plus Rs. 1,000 per device. Importers require the MD15 import license (Form MD14). All applications are filed on the SUGAM portal at cdscoonline.gov.in. Licenses are valid indefinitely with a five-year retention fee.
India's ENT medical device market is expanding rapidly in 2026, driven by a large and underserved patient population facing hearing impairment, chronic sinusitis, sleep-disordered breathing, and head and neck conditions that demand specialist otolaryngological care. With a growing network of ENT hospitals, audiology clinics, and cochlear implant programmes across both urban and tier-2 centres, demand for otolaryngology instruments, diagnostic systems, and implantable hearing devices has never been greater.
For every manufacturer and importer operating in this market, CDSCO registration is a mandatory pre-condition before any ENT device can be legally marketed or distributed in India. The regulatory framework under MDR 2017 is structured and consistent — but the license type, application form, fee, and licensing authority all depend on where your specific ENT device sits in CDSCO's four-class risk classification system. With 78 ENT devices formally notified across Classes A through D, verifying your device's exact class against CDSCO's published list is the single most important step before approaching the SUGAM portal.
📑 Quick Navigation
- What Are ENT Medical Devices?
- Market Opportunity in India 2026
- CDSCO Classification of ENT Medical Devices (Class A–D)
- ENT Device Examples by Class
- Licensing Pathways: MD5, MD9, and MD15
- Fee Structure
- Regulatory Framework at a Glance
- Document Checklist
- 7-Step CDSCO License Application Process
- Frequently Asked Questions
What Are ENT Medical Devices?
ENT medical devices are instruments, implants, diagnostic systems, and therapeutic equipment used by otolaryngologists — specialists in ear, nose, and throat medicine — to diagnose, monitor, and treat conditions of the auditory, nasal, sinus, pharyngeal, laryngeal, and related head and neck structures. The field spans an extraordinarily wide range of device complexity: from a simple tongue depressor or ear cup at one end, to a fully implantable cochlear implant system or bone-anchored hearing device at the other.
CDSCO regulates ENT medical devices under MDR 2017 because this category includes some of the most sophisticated implantable systems in medicine — devices that directly interface with the auditory nerve, reconstruct the ossicular chain of the middle ear, replace the larynx, or provide hearing via direct skull bone conduction. A cochlear implant that fails after surgical insertion can result in permanent hearing loss and require revision surgery. An ossicular prosthesis with poor biocompatibility can trigger chronic middle ear inflammation. A larynx prosthesis that does not maintain airway patency reliably puts the patient's breathing at immediate risk. India's risk-based classification and licensing framework for ENT devices reflects the clinical stakes involved at every level of the product spectrum.
Market Opportunity for ENT Medical Devices in India 2026
CDSCO Classification of ENT Medical Devices (Class A–D)
CDSCO classifies all 78 notified ENT medical devices into four risk-based classes under MDR 2017. The class of your device determines the license you need, the authority you apply to, the fee you pay, and the technical depth of documentation required. Because the ENT category spans such a wide range — from simple, non-contact diagnostic instruments to complex, surgically implanted hearing systems — correctly confirming your device's class is the essential first action before any registration work begins.
Non-invasive diagnostic aids and simple surgical instruments with minimal patient risk.
Devices that contact ear or nasal tissues, measure auditory function, or enable endoscopic ENT examination.
Invasive surgical systems, implantable prostheses, and active implantable hearing devices.
Highest risk class in ENT devices — direct contact hearing aid with the tympanic membrane.
ENT Device Examples by CDSCO Class
CDSCO has published a list of 78 ENT medical devices with their classifications under MDR 2017. The following examples — drawn from the official notified list — illustrate the range of devices in each class and help manufacturers and importers identify the correct license pathway before approaching the SUGAM portal.
- Adenotome
- Audiometer testing system (calibration reference)
- Bone particle collector
- Ear bowl
- Ear canal impression tray
- Ear canal light
- Ear excavator
- Endaural curette
- ENT cupped forceps
- ENT transilluminator
- External nasal splint
- Nasal septum straightening forceps
- Tonsil knife
- Tongue depressor
- Tonsillectome
- Tracheal bistoury
- Tracheal dilator
- Acoustic chamber for audiometric testing
- Adenotome blade
- Antistammering device
- Audiometer
- Auditory evoked-potential graphic recorder
- Behind-the-ear air-conduction hearing aid
- Behind-the-ear air-conduction tinnitus masker
- Ear wick
- Electroglottograph
- ENT chair (electric or mechanical)
- ENT nasal snare
- ENT shaver system
- ENT surgical microscope
- Epistaxis balloon
- Esophagoscope (flexible or rigid)
- Eustachian tube balloon dilation system
- Evoked-potential audiometer
- Flexible fibreoptic nasopharyngolaryngoscope
- Flexible fibreoptic rhinoscope / sinoscope
- Flexible video antroscope
- Hearing aid calibrator and analysis system
- Impedance audiometer
- Laryngostroboscope
- Master hearing aid
- Mediastinoscope and accessories
- Nasal dilator
- Otoscope (direct or endoscopic)
- Powered nasal irrigator
- Soft-tissue surgical forceps, alligator
- Wireless air-conduction hearing aid
- Active implantable bone conduction hearing system
- Anchored bone-conduction hearing implant system
- Argon laser for otology, rhinology, and laryngology
- Auditory stimulator
- Behind-the-ear bone-conduction tinnitus masker
- Cochlear implant assessment system
- Ear prosthesis
- Ear, nose, and throat electric or pneumatic surgical drill
- Ear, nose, and throat microsurgical carbon dioxide laser
- External upper esophageal sphincter compression device
- Fully-implantable middle ear implant system
- Gustometer
- Larynx prosthesis
- Mandibular implant facial prosthesis
- Middle ear mold
- Ossicular prosthesis (partial and total)
- Partial ossicular replacement prosthesis
- Sacculotomy tack (Cody tack)
- Suction antichoke device
- Tongs antichoke device
- Total ossicular replacement prosthesis
- Transcutaneous air conduction hearing aid system
- Tympanostomy tube with semipermeable membrane
- Tympanic membrane contact hearing aid
Licensing Pathways: MD5, MD9, and MD15
Your ENT device's CDSCO class determines which of three licensing pathways applies. Each pathway has a different form, a different licensing authority, different fees, and different documentation requirements. The most consequential distinction is between Class B hearing aids and endoscopes (MD5, SLA) and Class C cochlear implants, ossicular prostheses, and implantable bone conduction systems (MD9, CLA) — a distinction that is easy to get wrong without careful reference to the official list.
- Application form: Form MD3
- Issuing authority: State Licensing Authority (SLA)
- Portal: SUGAM — cdscoonline.gov.in
- Covers adenotomes, audiometers, otoscopes, hearing aids (air conduction), ENT surgical microscopes, ENT shaver systems, flexible fibreoptic endoscopes, impedance audiometers, epistaxis balloons, and all Class A surgical instruments
- Standard documentation review by SLA; facility inspection possible
- Valid indefinitely — 5-year retention fee
- Loan license (no own facility): MD6 via Form MD4
- Application form: Form MD7
- Issuing authority: Central Licensing Authority (CLA — CDSCO)
- Portal: SUGAM — cdscoonline.gov.in
- Covers cochlear implants, ossicular prostheses, larynx prostheses, bone-conduction implant systems, ENT laser systems, middle ear implants, tympanostomy tubes, mandibular implant prostheses, and tympanic membrane contact hearing aids
- Intensive CLA review — includes biocompatibility data, sterilisation validation (sterile devices), electromagnetic compatibility data (active implantable), and clinical performance evidence
- Valid indefinitely — 5-year retention fee
- Loan license (no own facility): MD10 via Form MD10
CDSCO ENT Device License Fee Structure
CDSCO's fee structure for ENT medical device licenses is fixed under MDR 2017 and payable through the SUGAM portal at the time of application. The fee varies by license type and is supplemented by a per-device fee for each distinct ENT device product listed in the application.
CDSCO Regulatory Framework for ENT Medical Devices — At a Glance
| Regulatory Parameter | Class A & B ENT Devices | Class C & D ENT Devices |
|---|---|---|
| Regulatory framework | Medical Devices Rules, 2017 (MDR 2017) | |
| Total notified ENT devices | 78 devices across all four classes | |
| Manufacturing license | MD5 | MD9 |
| Application form | Form MD3 | Form MD7 |
| Licensing authority | State Licensing Authority (SLA) | Central Licensing Authority (CLA — CDSCO) |
| Application portal | SUGAM — cdscoonline.gov.in | |
| License fee | ₹5,000 + ₹500/device | ₹50,000 + ₹1,000/device |
| Loan license (no facility) | MD6 · Form MD4 | MD10 · Form MD10 |
| Import license (all classes) | MD15 · Form MD14 · Central Licensing Authority | |
| License validity | Indefinite — subject to 5-year retention fee | |
| ISO 13485 mandatory | Yes — for all manufacturing license applications | |
| Biocompatibility data required | Sterile Class B devices / contact devices | Yes — all Class C and D devices |
| EMC / active implant data | Not applicable | Required for active implantable hearing devices (cochlear implants, bone-conduction systems) |
| Free Sale Certificate (import) | May be required | Required from FDA/EU/Japan/Australia/Canada |
Document Checklist for CDSCO ENT Medical Device Registration
Every document in your dossier must be current, internally consistent, and precisely matched to the ENT device types listed in your SUGAM application. For MD9 applications covering Class C/D ENT devices — particularly active implantable systems such as cochlear implants and bone-conduction hearing devices — the technical depth required is considerably greater than for MD5 applications, and includes electromagnetic compatibility data alongside standard biocompatibility and sterilisation records.
- Cover letter addressed to the correct authority — SLA for MD5 (Class A/B) or CLA for MD9 (Class C/D) — with complete applicant details, facility address, and ENT device types applied for
- Organisation identity proof — UDYAM Aadhaar registration, PAN card, or equivalent
- Constitution proof — GST Certificate, Certificate of Incorporation (CIN), Memorandum and Articles of Association (MOA/AOA)
- Sale Deed or Rent/Lease Deed of the manufacturing premises proving legal occupation at the address stated in the application
- Plant Master File (PMF) — complete description of the manufacturing facility: infrastructure, equipment, environmental controls, cleanroom classification (if applicable for sterile ENT devices), QMS overview, and GMP compliance documentation
- Device Master File (DMF) — full technical documentation for each ENT device type: intended use, design specifications, bill of materials, manufacturing process, biocompatibility evaluation, risk analysis, and QC specifications
- Certificate of Analysis for 3 consecutive production batches — covering every ENT device type in the application, demonstrating that finished products meet all specified quality and performance parameters
- Dimensioned building layout plan — technical drawings showing room-by-room equipment locations, cleanroom areas (where applicable), material flow paths, and personnel flow
- Personnel qualification documents — educational qualifications, work experience records, and training logs for manufacturing and QC staff
- Test License (if applicable) — if pilot or validation batches of ENT devices have been manufactured prior to the full commercial manufacturing license application
- ISO 13485 certificate — valid, issued by an accredited body, with scope explicitly covering the ENT or medical device categories applied for
- Fire NOC — from the local fire authority for the manufacturing premises
- Pollution NOC — from the state pollution control board
- Biocompatibility evaluation reports (sterile Class B and all Class C/D) — ISO 10993-series testing data for devices contacting the ear canal, tympanic membrane, middle ear, nasal mucosa, or surgically implanted tissues
- Sterilisation validation records (all sterile ENT devices) — demonstrating a validated sterilisation process achieving Sterility Assurance Level (SAL) of 10⁻⁶ for implantable ossicular prostheses, tympanostomy tubes, and surgical instruments
- Electromagnetic compatibility (EMC) and electromagnetic interference (EMI) data (active implantable ENT devices — MD9 only) — IEC 60601-series test data for cochlear implants, bone-conduction implant systems, and active middle ear implants
- Clinical performance evidence (Class C/D — MD9 only) — technical data supporting safety and performance claims for cochlear implant systems, ossicular prostheses, laryngeal prostheses, and tympanic membrane contact hearing aids
- Free Sale Certificates (MD15 import, Class C/D) — from recognised regulatory bodies (US FDA, EU, Japan PMDA, Australia TGA, Health Canada) confirming international market approval
How to Prepare the CDSCO Plant Master File in 2026
Learn what every section of the CDSCO Plant Master File must contain, how inspectors use it during facility audits, and the 10-step preparation process that produces an inspection-ready PMF for your MD5 or MD9 application.
7-Step CDSCO License Application Process for ENT Medical Devices
Here is the complete application pathway — from classification confirmation to license receipt — with the specific actions at each stage that determine whether your ENT device application moves efficiently or generates costly delays.
Before opening the SUGAM portal, verify the CDSCO classification for every ENT device you intend to manufacture or import using CDSCO's published notified list of 78 ENT devices. Pay close attention to the classification boundaries within the hearing device sub-category: behind-the-ear air-conduction hearing aids are Class B (MD5/SLA), transcutaneous air conduction hearing aids are Class C (MD9/CLA), and tympanic membrane contact hearing aids are Class D (MD9/CLA). Similarly, a standard otoscope is Class B, while a cochlear implant assessment system is also Class C — the same specialty, different risk classes, and entirely different licensing authorities. Filing the wrong form to the wrong authority results in rejection and a complete restart of the timeline and fee payment.
Create or sign in to your account on the CDSCO SUGAM portal at cdscoonline.gov.in. Confirm that your entity name, PAN number, and contact details exactly match your GST certificate and corporate identity documents. Discrepancies between the SUGAM account and supporting documents — even minor spelling variations in company name or abbreviated legal form — generate automatic system queries that add preventable processing delays at the submission stage.
For Class A/B ENT devices, complete Form MD3 for the MD5 license. For Class C/D ENT devices, complete Form MD7 for the MD9 license. For importing ENT devices of any class, complete Form MD14 for the MD15 license. Every field — device class, ENT device category name, intended use, facility address, and manufacturer details — must be accurate and must match your Device Master File, ISO 13485 certificate, and batch CoA in every particular. The most common cause of CLA queries in ENT device MD9 applications is a mismatch between the Form MD7 device description and the technical specifications in the DMF — particularly for active implantable hearing devices where the device name, intended hearing loss type, and implantation site must all be consistently described.
Prepare and upload all supporting documents through SUGAM. For Class C/D MD9 applications, ensure biocompatibility data covers all tissue contact categories relevant to your ENT device (ISO 10993 series); for sterile implantable devices, sterilisation validation must demonstrate SAL 10⁻⁶; and for active implantable hearing systems (cochlear implants, bone-conduction implant systems), electromagnetic compatibility and electromagnetic interference test records per IEC 60601-series are required. Check that your ISO 13485 certificate scope explicitly names ENT, audiology, or the appropriate medical device category — a scope limited to "medical devices" without specifying ENT or implantable hearing devices may generate a CLA query requesting an updated or expanded certificate.
Pay the prescribed CDSCO application fee through SUGAM: Rs. 5,000 plus Rs. 500 per device for MD5; Rs. 50,000 plus Rs. 1,000 per device for MD9. If applying for multiple distinct ENT device types — for example, both a cochlear implant system and an ossicular prosthesis under a single MD9 application — calculate the total per-device fee for each product accurately before submitting. Payment is made digitally and must be completed before formal submission. Retain the payment confirmation receipt in your license file.
The SLA (MD5) or CLA (MD9) reviews your submitted application and documents. For Class C/D ENT devices, the CLA review is comprehensive — including technical assessment of biocompatibility data for implantable ossicular and laryngeal prostheses, sterilisation validation for surgical ENT instruments and tympanostomy tubes, EMC/EMI data for cochlear implants and active hearing systems, and clinical evidence of hearing gain or audiological performance for hearing implants. Monitor your SUGAM dashboard actively. Respond to every query completely and with supporting documentary evidence within the response window. For cochlear implant and bone-conduction implant MD9 applications in particular, CLA queries often require substantive clinical and technical responses rather than document substitutions — build this into your project timeline from the outset.
CDSCO or the SLA may schedule an on-site inspection of your ENT device manufacturing facility, particularly for Class C/D implantable and active devices where cleanroom conditions, sterilisation equipment, electronic assembly quality controls, and acoustic testing infrastructure are relevant. Ensure your Plant Master File accurately describes the facility as it currently exists — inspectors cross-check physical conditions, equipment records, and personnel qualifications against the PMF in detail. Run a thorough internal pre-inspection audit before the official visit. Once all criteria are satisfied, the license is issued. Verify every detail on the MD5 or MD9 license — device names, classification, facility address, and CLA or SLA reference — before commencing commercial production or distribution.
Frequently Asked Questions
What is the difference between MD9 and MD15 for ENT devices?
The MD9 license is for manufacturing Class C and D ENT devices in India, applied via Form MD7 to the Central Licensing Authority. The MD15 license is for importing ENT devices of any class into India, applied via Form MD14 to the Central Licensing Authority. A company that both manufactures in India and imports additional ENT products requires both licenses. Foreign manufacturers who export ENT devices to India do not need an MD9 — their authorised Indian agent applies for the MD15 import license on their behalf.
Is ISO 13485 mandatory for ENT device registration in India?
Yes. ISO 13485 certification is mandatory for all CDSCO MD5 and MD9 manufacturing license applications, including all ENT medical devices. The certificate must be current, issued by an accredited certification body, and explicitly scoped to the ENT or medical device categories you intend to manufacture. For cochlear implant and active implantable hearing system manufacturers, the certificate scope should ideally reference active implantable devices or implantable auditory systems — a generic scope may generate a query from the CLA during the MD9 review process.
Are cochlear implants classified as Class C or Class D by CDSCO?
Cochlear implants and related active implantable hearing systems — including anchored bone-conduction hearing implant systems and active implantable bone conduction hearing systems — are classified as Class C under CDSCO's MDR 2017 classification. They require the MD9 manufacturing license (Form MD7) from the Central Licensing Authority. The only ENT device classified as Class D is the tympanic membrane contact hearing aid, which compensates for hearing impairment via a transducer in direct physical contact with the tympanic membrane.
Do Free Sale Certificates from other countries help with CDSCO MD15 ENT device import registration?
Yes — and for Class C and D ENT devices, they are typically required. CDSCO's MD15 import license process for higher-risk ENT devices requires Free Sale Certificates from recognised global regulatory bodies — the US FDA, the European Union, Japan's PMDA, Australia's TGA, or Health Canada. For cochlear implants and bone-conduction implant systems in particular, which are typically first approved in the US or EU markets, these certificates serve as primary evidence of safety and performance compliance and materially support the CLA's technical review of the MD15 dossier.
Can a single MD9 license cover multiple Class C ENT device types?
Yes. A single MD9 license can cover multiple Class C and/or D ENT device types manufactured at the same facility, provided each product is listed in the Form MD7 application and the Device Master File includes product-specific documentation — intended use, specifications, manufacturing process, biocompatibility data, EMC data (for active devices), and QC programme — for each device. Adding new ENT device types after the initial license grant requires a variation application to the CLA, not a new MD9 license application. This makes it advisable to consolidate all ENT device types you intend to produce into a single well-prepared MD9 submission rather than filing incremental additions later.
✓ Key Takeaways
- ENT medical devices in India are regulated under MDR 2017, with 78 devices formally notified across four risk classes — A, B, C, and D
- Class A and B ENT devices (adenotomes, audiometers, otoscopes, hearing aids, ENT surgical microscopes, flexible endoscopes) require the MD5 license via Form MD3 — fees Rs. 5,000 + Rs. 500/device — from the State Licensing Authority
- Class C and D ENT devices (cochlear implants, ossicular prostheses, larynx prostheses, bone-conduction implant systems, ENT laser systems, tympanic membrane contact hearing aids) require the MD9 license via Form MD7 — fees Rs. 50,000 + Rs. 1,000/device — from the Central Licensing Authority
- Importers of ENT devices of any class require the MD15 import license (Form MD14) from the CLA; Class C/D imports typically require Free Sale Certificates from US FDA, EU, Japan, Australia, or Canada
- All applications are filed through the SUGAM portal at cdscoonline.gov.in
- Licenses are valid indefinitely but require a five-year retention fee to remain active
- ISO 13485 certification is mandatory — the certificate scope must explicitly cover the ENT or implantable device categories being manufactured
- Class C/D MD9 applications for active implantable ENT devices require biocompatibility data (ISO 10993), sterilisation validation, EMC/EMI test records, and clinical performance evidence
- ENT hearing devices span three different classes — Class B (air-conduction hearing aids), Class C (transcutaneous and active implantable systems), and Class D (tympanic membrane contact) — confirming the exact class before filing is essential
- Confirm your device's CDSCO class against the 78-device notified list before opening SUGAM — filing the wrong form to the wrong authority restarts the timeline from zero
Your Next Step
CDSCO registration for ENT medical devices in India is a clearly structured process in 2026 — but one that demands careful preparation, particularly for Class C implantable hearing systems, ossicular prostheses, laryngeal prostheses, and ENT laser platforms subject to the CLA's MD9 review. The ENT device category's breadth — 78 notified devices across four risk classes — means that classification errors are common and consequential. Getting the class right before filing determines everything that follows: the authority, the form, the fee, and the documentation standard.
The commercial opportunity in India's ENT device market is real, growing, and supported by expanding public health infrastructure. Manufacturers and importers who invest in thorough documentation — a Device Master File specific to each ENT product, an ISO 13485 certificate correctly scoped, complete biocompatibility and EMC validation records for active implantables — consistently achieve faster, smoother application outcomes than those who submit quickly and manage queries reactively.
Speak to a Rego Services regulatory consultant today to confirm your ENT device's CDSCO class, identify the correct license pathway, and build a documentation strategy that produces a complete, query-ready SUGAM application from first submission.